We are live on ! Find out more
TAM

Tocqueville Asset Management Portfolio holdings

AUM $7.56B
1-Year Est. Return 44.87%
This Fund
S&P 500
This Quarter Est. Return
-0.99%
1 Year Est. Return
+44.87%
3 Year Est. Return
+121.98%
5 Year Est. Return
+153.06%
10 Year Est. Return
+501.33%
AUM
$6.12B
AUM Growth
-$252M
Cap. Flow
-$50M
Cap. Flow %
-0.82%
Top 10 Hldgs %
25.79%
Holding
562
New
24
Increased
161
Reduced
223
Closed
49

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$59.1M
2
UBER icon
Uber
UBER
+$57.9M
3
UNH icon
UnitedHealth
UNH
+$55.4M
4
VRT icon
Vertiv
VRT
+$21.8M
5
AVAV icon
AeroVironment
AVAV
+$21.6M

Top Sells

Rank Stock Value
1
FLEX icon
Flex
FLEX
+$28.5M
2
AAPL icon
Apple
AAPL
+$19.1M
3
PGR icon
Progressive
PGR
+$17.3M
4
DUK icon
Duke Energy
DUK
+$17.1M
5
HD icon
Home Depot
HD
+$16.8M

Sector Composition

Rank Sector Weight
1 Technology 20.55%
2 Industrials 12.51%
3 Healthcare 12.24%
4 Consumer Discretionary 11.04%
5 Financials 10.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCO icon
501
Moody's
MCO
$88.4B
$210K ﹤0.01%
450
-25
-5% -$12K
PFF icon
502
iShares Preferred and Income Securities ETF
PFF
$13.1B
$205K ﹤0.01%
+6,660
New +$210K
ZGN icon
503
Zegna
ZGN
$3.64B
$195K ﹤0.01%
26,350
BCYC
504
Bicycle Therapeutics
BCYC
$303M
$155K ﹤0.01%
18,300
+3,600
+24% +$42.4K
LXP icon
505
LXP Industrial Trust
LXP
$3.6B
$136K ﹤0.01%
3,136
MAMA icon
506
Mama's Creations
MAMA
$744M
$115K ﹤0.01%
17,725
ESPR
507
DELISTED
Esperion Therapeutics
ESPR
$93.6K ﹤0.01%
65,000
-5,000
-7% -$9.21K
CCC
508
CCC Intelligent Solutions
CCC
$4.46B
$90.3K ﹤0.01%
+10,000
New +$104K
UFI icon
509
UNIFI
UFI
$142M
$56.1K ﹤0.01%
11,666
IMMX icon
510
Immix Biopharma
IMMX
$1.04B
$49.2K ﹤0.01%
29,300
-9,000
-23% -$17K
TCRX icon
511
TScan Therapeutics
TCRX
$51.3M
$37.3K ﹤0.01%
27,000
-233,870
-90% -$506K
DRRX
512
DELISTED
DURECT Corp
DRRX
$15.1K ﹤0.01%
18,830
CGTX icon
513
Cognition Therapeutics
CGTX
$101M
$12K ﹤0.01%
28,500
AA icon
514
Alcoa
AA
$13.6B
-8,025
Closed -$303K
AAT
515
American Assets Trust
AAT
$1.39B
-8,048
Closed -$211K
BALL icon
516
Ball Corp
BALL
$16.8B
-46,815
Closed -$2.58M
BBH icon
517
VanEck Biotech ETF
BBH
$471M
-5,478
Closed -$860K
BIO icon
518
Bio-Rad Laboratories Class A
BIO
$10.5B
-3,918
Closed -$1.29M
BTAI icon
519
BioXcel Therapeutics
BTAI
$22.5M
-738
Closed -$4.41K
CAG icon
520
Conagra Brands
CAG
$7.71B
-7,338
Closed -$204K
CAH icon
521
Cardinal Health
CAH
$54.6B
-1,697
Closed -$201K
CELH icon
522
Celsius Holdings
CELH
$8.39B
-206,339
Closed -$5.43M
CF icon
523
CF Industries
CF
$19B
-2,815
Closed -$240K
CNI icon
524
Canadian National Railway
CNI
$76.6B
-3,211
Closed -$326K
CNQ icon
525
Canadian Natural Resources
CNQ
$103B
-56,424
Closed -$1.74M

Similar funds

Tocqueville Asset Management's Q1 2025 Portfolio in Review

As of Q1 2025, Tocqueville Asset Management held 562 positions worth $6.12B, down 4% from $6.38B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Tocqueville Asset Management's Q1 2025 filing shows 24 new, 161 increased, 223 reduced and 49 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 85,929 shares worth $54.5M. The largest sale was Flex, an estimated $28.5M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Industrials and Healthcare.

  • Tocqueville Asset Management's largest Q1 2025 buy was Regeneron Pharmaceuticals: 85,929 shares worth $54.5M.
  • Tocqueville Asset Management added most to UnitedHealth in Q1 2025, an estimated $55.4M increase.
  • Tocqueville Asset Management's biggest Q1 2025 reduction was Flex, cutting an estimated $28.5M.
  • Tocqueville Asset Management fully exited Celsius Holdings in Q1 2025, selling an estimated $5.43M.
  • Tocqueville Asset Management's ten largest holdings make up 26% of its $6.12B portfolio in Q1 2025.
  • Tocqueville Asset Management opened 24 new positions and closed 49 in Q1 2025.
  • Tocqueville Asset Management's portfolio value fell 4% quarter-over-quarter to $6.12B.

Based on Tocqueville Asset Management's 13F filing for Q1 2025, filed 13 May 2025.